Results overview: Found 1 records in 0.01 seconds.
Articles, 1 records found
Articles 1 records found  
1.
14 p, 6.3 MB CD40-activated B cells induce anti-tumor immunity in vivo / Wennhold, Kerstin (Uniklinik Köln (Colònia, Alemanya)) ; Weber, Tanja M. (Cologne Interventional Immunology (CII), Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany) ; Klein-Gonzalez, Nela (Hospital Universitari Vall d'Hebron) ; Thelen, Martin (Uniklinik Köln (Colònia, Alemanya)) ; Garcia-Marquez, Maria (Uniklinik Köln (Colònia, Alemanya)) ; Chakupurakal, Geothy (Uniklinik Köln (Colònia, Alemanya)) ; Fiedler, Anne (Uniklinik Köln (Colònia, Alemanya)) ; Schlösser, Hans A. (Department of General, Visceral and Cancer Surgery, University Hospital of Cologne) ; Fischer, Rieke (Department I of Internal Medicine, University Hospital of Cologne) ; Theurich, Sebastian (Max Planck Institute for Metabolism Research Cologne) ; Shimabukuro-Vornhagen, Alexander (Uniklinik Köln (Colònia, Alemanya)) ; von Bergwelt-Baildon, Michael (Uniklinik Köln (Colònia, Alemanya)) ; Vall d'Hebron Institut de Recerca (VHIR) ; Universitat Autònoma de Barcelona
The introduction of checkpoint inhibitors represents a major advance in cancer immunotherapy. Some studies on checkpoint inhibition demonstrate that combinatorial immunotherapies with secondary drivers of anti-tumor immunity provide beneficial effects for patients that do not show a strong endogenous immune response. [...]
2016 - 10.18632/oncotarget.7720
Oncotarget, Vol. 8 (february 2016) , p. 27740-27753  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.